» Articles » PMID: 15246565

Antisense-mediated VEGF Suppression in Bladder and Breast Cancer Cells

Overview
Journal Cancer Lett
Specialty Oncology
Date 2004 Jul 13
PMID 15246565
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Angiogenesis plays a key role in tumor growth and metastasis. Vascular endothelial growth factor (VEGF) is one of the major angiogenic factors. In the study we have evaluated the efficiency of antisense oligodeoxynucleotides (AS-ODN) against VEGF selected from computational prediction of VEGF mRNA structure. Twenty-five different AS-ODN in two different tumor cell lines were investigated. Treatment of cell line EJ28 by VEGF723 resulted in a 83.5% suppression of VEGF protein when compared with control-ODN. Three further AS-ODN reduced VEGF protein more than 45% in comparison to control-ODN. This was caused by an antisense-specific downregulation of the VEGF transcript determined by real-time PCR. Furthermore, antisense-mediated inhibition of VEGF was associated by a reduced cell viability. In MCF-7 cells VEGF protein was inhibited more than 45% by two AS-ODN. In conclusion, we found that computational prediction of potential single strand mRNA motifs is a well suitable method to elect effective AS-ODN.

Citing Articles

Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics.

Le B, Raguraman P, Kosbar T, Fletcher S, Wilton S, Veedu R Mol Ther Nucleic Acids. 2018; 14:142-157.

PMID: 30594893 PMC: 6307321. DOI: 10.1016/j.omtn.2018.11.007.


Systematic evaluation of oligodeoxynucleotide binding and hybridization to modified multi-walled carbon nanotubes.

Kaufmann A, Hampel S, Rieger C, Kunhardt D, Schendel D, Fussel S J Nanobiotechnology. 2017; 15(1):53.

PMID: 28716122 PMC: 5513106. DOI: 10.1186/s12951-017-0288-z.


The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy.

Aldebasi Y, Rahmani A, Khan A, Aly S Int J Clin Exp Med. 2013; 6(4):239-51.

PMID: 23641300 PMC: 3631548.


Gemcitabine and paclitaxel suppress the production of vascular endothelial growth factor induced by deferoxamine in human non-small cell lung cancer A549 cells.

Ikeda R, Vermeulen L, Jiang Z, Lau E, Kolesar J Exp Ther Med. 2012; 1(5):853-857.

PMID: 22993609 PMC: 3445941. DOI: 10.3892/etm.2010.130.


New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids.

Patutina O, Mironova N, Vlassov V, Zenkova M Acta Naturae. 2012; 1(2):44-60.

PMID: 22649602 PMC: 3347510.